한글목차

식물 유래 원료의약품(API) 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2025년 320억 8,000만 달러에서 2026년에는 342억 달러에 이르고, CAGR 6.6%로 성장할 전망입니다. 지난 몇 년간의 성장은 전통 의학의 보급, 약용 식물의 가용성, 합성 API에 대한 비용 우위, 한약제제의 성장, 천연물에 대한 소비자 선호도 증가에 기인하는 것으로 보입니다.

식물 유래 원료의약품(API) 시장 규모는 향후 몇 년간 견고성장이 전망됩니다. 2030년에는 440억 5,000만 달러에 이르고, CAGR은 6.5%를 나타낼 전망입니다. 예측 기간의 성장 요인으로는 지속가능성 중심의 API 조달, 식물 유래 의약품 파이프라인 확대, 건강기능식품과 의약품의 경계 영역 확대, 표준화 기술 향상, 친환경 의약품에 대한 세계 수요를 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 천연 및 허브 API에 대한 수요 증가, 식물 화학물질 추출 기술 확대, 만성질환 치료에서 식물 API 활용 확대, 허브 API에 대한 규제적 수용 확대, 지속 가능한 API 조달로의 전환 등이 있습니다.

천연-유기농 제품에 대한 소비자 수요 증가는 식물 유래 원료의약품(API) 시장의 확대를 촉진할 것으로 예측됩니다. 천연-유기농 제품이란 천연 유래 원료로 제조되고 최소한의 가공만을 거치며 합성화학물질이나 유전자변형생물체(GMO)를 포함하지 않은 제품을 말합니다. 이러한 변화는 건강에 대한 인식이 높아지고 합성 화학물질에 대한 우려가 높아지면서 인공 성분이 건강에 미치는 위험에 대한 인식이 높아졌기 때문입니다. 식물 유래 API는 소비자가 원하는 순수하고 안전하며 친환경적인 건강 선택에 부합하는 화학 물질이 없는 강력한 치료 효과를 제공함으로써 천연 및 유기농 제품을 실현할 수 있습니다. 예를 들어, 2025년 4월 미국 유기농 무역협회가 발표한 바에 따르면 2024년 미국 내 인증 유기농 제품 매출은 5.2% 증가하여 전체 시장 성장률 2.5%를 두 배 이상 상회하는 716억 달러로 사상 최고치를 기록했다고 합니다. 이처럼 천연-유기농 제품에 대한 선호도가 높아지면서 식물 유래 원료의약품(API) 시장의 성장을 견인하고 있습니다.

식물 유래 원료의약품(API) 시장의 주요 기업들은 식물 유래 스쿠알렌과 같은 새로운 제품 개발에 우선순위를 두고 있으며, 기존의 동물성 원료를 대체할 수 있는 친환경적이고 윤리적인 대안을 제공합니다. 식물 유래 스쿠알렌은 상어 유래 스쿠알렌의 지속 가능하고 윤리적인 대안으로 아마란스, 올리브, 사탕수수 등의 원료로 제조되어 의약품, 화장품, 백신 등의 용도로 활용되고 있습니다. 예를 들어, 2023년 10월 독일에 본사를 둔 특수 화학 기업 에보닉 인더스트리즈(Evonik Industries AG)는 아마란스 오일에서 추출한 식물성 스쿠알렌으로 최초의 GMP 등급 제품인 '피토스쿠엔'을 발표했습니다. 이 획기적인 제품은 상어에서 추출한 스쿠알렌을 대체할 수 있는 친환경적인 대안으로 순도가 우수하고, 배치 간 균일성이 뛰어나며, 유럽 약전(Ph. Eur.)의 요구사항을 충족하는 등 친환경적인 제품입니다. 스쿠알렌은 백신 보조제에서 면역반응을 촉진하는 중요한 성분입니다. 이 식물 유래 솔루션을 통해 피토스퀸은 생물 다양성 문제에 대응하고, 동물성 원료에 대한 의존도를 낮추며, 문화적, 종교적 요구에 부합할 수 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Plant-based active pharmaceutical ingredients (APIs) are biologically active compounds obtained from plants that are used in the development of medications. These ingredients play a vital role due to their therapeutic properties, which may involve treating, preventing, or managing different health conditions.

The primary categories of plant-based active pharmaceutical ingredients (APIs) include alkaloids, glycosides, cannabinoids, flavonoids, terpenes and terpenoids, polyphenols, saponins, and additional types. Alkaloids form a varied class of naturally occurring organic substances that typically feature basic nitrogen atoms. Plant-derived APIs come from diverse origins, such as leaves, roots, bark, flowers, seeds, fruits, resins, gums, and various other natural materials. These compounds reach consumers via several distribution methods, including online stores, supermarkets and hypermarkets, specialty health shops, and foodservice outlets, serving a range of sectors like pharmaceuticals, nutraceuticals, herbal products, and more.

Tariffs have affected the plant-based active pharmaceutical ingredients market by increasing the cost of imported botanical raw materials, extraction solvents, and processing equipment used in plant API production. These impacts have been most pronounced in alkaloid and cannabinoid API segments, particularly in north america and europe where sourcing depends on international plant supply chains. Asia-pacific producers have faced export pricing pressures due to trade barriers. However, tariffs have encouraged domestic cultivation of medicinal plants and localized extraction facilities, supporting supply security and sustainable manufacturing growth.

The plant-based active pharmaceutical ingredients (api) market research report is one of a series of new reports from The Business Research Company that provides plant-based active pharmaceutical ingredients (api) market statistics, including plant-based active pharmaceutical ingredients (api) industry global market size, regional shares, competitors with a plant-based active pharmaceutical ingredients (api) market share, detailed plant-based active pharmaceutical ingredients (api) market segments, market trends and opportunities, and any further data you may need to thrive in the plant-based active pharmaceutical ingredients (api) industry. This plant-based active pharmaceutical ingredients (api) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The plant-based active pharmaceutical ingredients (api) market size has grown strongly in recent years. It will grow from $32.08 billion in 2025 to $34.2 billion in 2026 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to traditional medicine adoption, availability of medicinal plants, cost advantages over synthetic APIs, growth of herbal drug formulations, rising consumer preference for natural products.

The plant-based active pharmaceutical ingredients (api) market size is expected to see strong growth in the next few years. It will grow to $44.05 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to sustainability-driven API sourcing, expansion of plant-based drug pipelines, rising nutraceutical-pharma overlap, improved standardization techniques, global demand for green pharmaceuticals. Major trends in the forecast period include rising demand for natural and herbal APIs, expansion of phytochemical extraction technologies, growing use of plant APIs in chronic therapies, increasing regulatory acceptance of herbal APIs, shift toward sustainable API sourcing.

The rising consumer demand for natural and organic products is poised to fuel expansion in the plant-based active pharmaceutical ingredients (API) market. Natural and organic products are those derived from naturally sourced materials, undergo minimal processing, and exclude synthetic chemicals as well as genetically modified organisms (GMOs). This shift stems from heightened health awareness and worries about synthetic chemicals, with people increasingly mindful of the health risks posed by artificial ingredients. Plant-based APIs enable natural and organic products by delivering potent, chemical-free therapeutic effects that match consumer desires for pure, secure, and eco-friendly health options. For instance, in April 2025, the Organic Trade Association-a U.S.-based group for member businesses-reported that certified organic product sales in the U.S. surged 5.2% in 2024, outpacing the overall market's 2.5% growth by more than double, and reaching a record $71.6 billion. Thus, the increasing preference for natural and organic products is propelling the plant-based active pharmaceutical ingredients (API) market forward.

Major companies in the plant-based active pharmaceutical ingredients (API) market are prioritizing the creation of novel products like plant-based squalene, offering eco-friendly and ethical substitutes for conventional animal-sourced materials. Plant-based squalene serves as a sustainable, ethical replacement for squalene from sharks, derived from sources such as amaranth, olives, and sugarcane for applications in pharmaceuticals, cosmetics, and vaccines. For example, in October 2023, Evonik Industries AG-a specialty chemicals firm based in Germany-introduced PhytoSquene, the inaugural GMP-grade, plant-derived squalene from amaranth oil. This breakthrough delivers a green alternative to shark-sourced squalene, with superior purity, reliable batch consistency, and adherence to European Pharmacopoeia (Ph. Eur.) requirements. Squalene is vital in vaccine adjuvants, boosting immune reactions. Through this plant-based solution, PhytoSquene tackles biodiversity issues, cuts dependence on animal products, and aligns with cultural and religious needs.

In March 2024, Roquette Freres, a French supplier of pharmaceutical excipients, purchased IFF Pharma Solutions for an undisclosed sum. Through this acquisition, Roquette seeks to bolster its standing in the pharmaceutical excipients sector by broadening its product range and expertise in drug delivery. The deal speeds up expansion in the health and nutrition markets, solidifying Roquette's status as a vital collaborator for pharma firms. IFF Pharma Solutions, a U.S.-based firm, specializes in plant-derived active pharmaceutical ingredients.

Major companies operating in the plant-based active pharmaceutical ingredients (api) market are Indena S.p.A., Centroflora Group, Alkaloids Corporation, Alchem International Pvt. Ltd., C2 Pharma, Brains Bioceutical Corp., Bright Green Corporation, Sichuan Xieli Pharmaceutical Co. Ltd., Roquette Freres, Koninklijke DSM N.V., Evonik Industries AG, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Alembic Pharmaceuticals Ltd., Seppic, PAI Pharma, SCL Lifesciences Ltd., AMGIS Lifescience Ltd., Organotechnie, HimPharm

North America was the largest region in the plant-based active pharmaceutical ingredients (API) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plant-based active pharmaceutical ingredients (api) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the plant-based active pharmaceutical ingredients (api) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The plant-based active pharmaceutical ingredients (API) market consists of sales of botanical extracts, plant-based steroids, essential oils, flavonoids, and botanical extracts. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Plant-Based Active Pharmaceutical Ingredients (API) Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses plant-based active pharmaceutical ingredients (api) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for plant-based active pharmaceutical ingredients (api) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The plant-based active pharmaceutical ingredients (api) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Alkaloids; Glycosides; Cannabinoids; Flavonoid; Terpenes And Terpenoids; Polyphenols; Saponins; Other Product Types
• 2) By Source: Leaves; Roots; Bark; Flowers; Seeds; Fruits; Resin And Gums; Other Sources
• 3) By Distribution Channel: Online Retailers; Supermarkets Or Hypermarkets; Specialty Food Stores; Foodservice
• 4) By End-Use: Pharmaceuticals; Nutraceuticals; Herbal Based Industries; Other End-Uses
• Subsegments:
• 1) By Alkaloids: Morphine Alkaloids; Tropane Alkaloids; Quinolizidine Alkaloids; Indole Alkaloids; Isoquinoline Alkaloids; Pyrrolizidine Alkaloids
• 2) By Glycosides: Cardiac Glycosides; Anthraquinone Glycosides; Flavonoid Glycosides; Saponin Glycosides; Cyanogenic Glycosides
• 3) By Cannabinoids: Tetrahydrocannabinol (THC); Cannabidiol (CBD); Cannabigerol (CBG); Cannabichromene (CBC); Cannabinol (CBN)
• 4) By Flavonoid: Flavones; Flavonols; Isoflavones; Flavanones; Anthocyanins
• 5) By Terpenes And Terpenoids: Monoterpenes; Sesquiterpenes; Diterpenes; Triterpenes; Tetraterpenes
• 6) By Polyphenols: Phenolic Acids; Stilbenes; Lignans; Flavonoid Polyphenols
• 7) By Saponins: Steroidal Saponins; Triterpenoid Saponins
• 8) By Other Product Types: Coumarins; Tannins; Lignins; Phenolic Glycosides
• Companies Mentioned: Indena S.p.A.; Centroflora Group; Alkaloids Corporation; Alchem International Pvt. Ltd.; C2 Pharma; Brains Bioceutical Corp.; Bright Green Corporation; Sichuan Xieli Pharmaceutical Co. Ltd.; Roquette Freres; Koninklijke DSM N.V.; Evonik Industries AG; Sun Pharmaceutical Industries Ltd.; Aurobindo Pharma Limited; Alembic Pharmaceuticals Ltd.; Seppic; PAI Pharma; SCL Lifesciences Ltd.; AMGIS Lifescience Ltd.; Organotechnie; HimPharm
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Plant-Based Active Pharmaceutical Ingredients (API) Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Plant-Based Active Pharmaceutical Ingredients (API) Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Plant-Based Active Pharmaceutical Ingredients (API) Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Plant-Based Active Pharmaceutical Ingredients (API) Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Sustainability, Climate Tech & Circular Economy
  • 4.1.2 Biotechnology, Genomics & Precision Medicine
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.5 Artificial Intelligence & Autonomous Intelligence
• 4.2. Major Trends
  • 4.2.1 Rising Demand For Natural And Herbal Apis
  • 4.2.2 Expansion Of Phytochemical Extraction Technologies
  • 4.2.3 Growing Use Of Plant Apis In Chronic Therapies
  • 4.2.4 Increasing Regulatory Acceptance Of Herbal Apis
  • 4.2.5 Shift Toward Sustainable Api Sourcing

5. Plant-Based Active Pharmaceutical Ingredients (API) Market Analysis Of End Use Industries

• 5.1 Pharmaceutical Companies
• 5.2 Nutraceutical Manufacturers
• 5.3 Herbal Medicine Producers
• 5.4 Research Institutions
• 5.5 Contract Api Manufacturers

6. Plant-Based Active Pharmaceutical Ingredients (API) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Plant-Based Active Pharmaceutical Ingredients (API) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Plant-Based Active Pharmaceutical Ingredients (API) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Plant-Based Active Pharmaceutical Ingredients (API) Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Plant-Based Active Pharmaceutical Ingredients (API) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Plant-Based Active Pharmaceutical Ingredients (API) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Plant-Based Active Pharmaceutical Ingredients (API) Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Plant-Based Active Pharmaceutical Ingredients (API) Market Segmentation

• 9.1. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Alkaloids, Glycosides, Cannabinoids, Flavonoid, Terpenes And Terpenoids, Polyphenols, Saponins, Other Product Types
• 9.2. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Leaves, Roots, Bark, Flowers, Seeds, Fruits, Resin And Gums, Other Sources
• 9.3. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Online Retailers, Supermarkets Or Hypermarkets, Specialty Food Stores, Foodservice
• 9.4. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pharmaceuticals, Nutraceuticals, Herbal Based Industries, Other End-Uses
• 9.5. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Sub-Segmentation Of Alkaloids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Morphine Alkaloids, Tropane Alkaloids, Quinolizidine Alkaloids, Indole Alkaloids, Isoquinoline Alkaloids, Pyrrolizidine Alkaloids
• 9.6. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Sub-Segmentation Of Glycosides, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cardiac Glycosides, Anthraquinone Glycosides, Flavonoid Glycosides, Saponin Glycosides, Cyanogenic Glycosides
• 9.7. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Sub-Segmentation Of Cannabinoids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Tetrahydrocannabinol (THC), Cannabidiol (CBD), Cannabigerol (CBG), Cannabichromene (CBC), Cannabinol (CBN)
• 9.8. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Sub-Segmentation Of Flavonoid, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Flavones, Flavonols, Isoflavones, Flavanones, Anthocyanins
• 9.9. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Sub-Segmentation Of Terpenes And Terpenoids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Monoterpenes, Sesquiterpenes, Diterpenes, Triterpenes, Tetraterpenes
• 9.10. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Sub-Segmentation Of Polyphenols, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Phenolic Acids, Stilbenes, Lignans, Flavonoid Polyphenols
• 9.11. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Sub-Segmentation Of Saponins, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Steroidal Saponins, Triterpenoid Saponins
• 9.12. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Coumarins, Tannins, Lignins, Phenolic Glycosides

10. Plant-Based Active Pharmaceutical Ingredients (API) Market Regional And Country Analysis

• 10.1. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Plant-Based Active Pharmaceutical Ingredients (API) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Plant-Based Active Pharmaceutical Ingredients (API) Market

• 11.1. Asia-Pacific Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Plant-Based Active Pharmaceutical Ingredients (API) Market

• 12.1. China Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Plant-Based Active Pharmaceutical Ingredients (API) Market

• 13.1. India Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Plant-Based Active Pharmaceutical Ingredients (API) Market

• 14.1. Japan Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Plant-Based Active Pharmaceutical Ingredients (API) Market

• 15.1. Australia Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Plant-Based Active Pharmaceutical Ingredients (API) Market

• 16.1. Indonesia Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Plant-Based Active Pharmaceutical Ingredients (API) Market

• 17.1. South Korea Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Plant-Based Active Pharmaceutical Ingredients (API) Market

• 18.1. Taiwan Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Plant-Based Active Pharmaceutical Ingredients (API) Market

• 19.1. South East Asia Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Plant-Based Active Pharmaceutical Ingredients (API) Market

• 20.1. Western Europe Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Plant-Based Active Pharmaceutical Ingredients (API) Market

• 21.1. UK Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Plant-Based Active Pharmaceutical Ingredients (API) Market

• 22.1. Germany Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Plant-Based Active Pharmaceutical Ingredients (API) Market

• 23.1. France Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Plant-Based Active Pharmaceutical Ingredients (API) Market

• 24.1. Italy Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Plant-Based Active Pharmaceutical Ingredients (API) Market

• 25.1. Spain Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Plant-Based Active Pharmaceutical Ingredients (API) Market

• 26.1. Eastern Europe Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Plant-Based Active Pharmaceutical Ingredients (API) Market

• 27.1. Russia Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Plant-Based Active Pharmaceutical Ingredients (API) Market

• 28.1. North America Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Plant-Based Active Pharmaceutical Ingredients (API) Market

• 29.1. USA Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Plant-Based Active Pharmaceutical Ingredients (API) Market

• 30.1. Canada Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Plant-Based Active Pharmaceutical Ingredients (API) Market

• 31.1. South America Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Plant-Based Active Pharmaceutical Ingredients (API) Market

• 32.1. Brazil Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Plant-Based Active Pharmaceutical Ingredients (API) Market

• 33.1. Middle East Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Plant-Based Active Pharmaceutical Ingredients (API) Market

• 34.1. Africa Plant-Based Active Pharmaceutical Ingredients (API) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Plant-Based Active Pharmaceutical Ingredients (API) Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Plant-Based Active Pharmaceutical Ingredients (API) Market Regulatory and Investment Landscape

36. Plant-Based Active Pharmaceutical Ingredients (API) Market Competitive Landscape And Company Profiles

• 36.1. Plant-Based Active Pharmaceutical Ingredients (API) Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Plant-Based Active Pharmaceutical Ingredients (API) Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Plant-Based Active Pharmaceutical Ingredients (API) Market Company Profiles
  • 36.3.1. Indena S.p.A. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Centroflora Group Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Alkaloids Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Alchem International Pvt. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. C2 Pharma Overview, Products and Services, Strategy and Financial Analysis

37. Plant-Based Active Pharmaceutical Ingredients (API) Market Other Major And Innovative Companies

• Brains Bioceutical Corp., Bright Green Corporation, Sichuan Xieli Pharmaceutical Co. Ltd., Roquette Freres, Koninklijke DSM N.V., Evonik Industries AG, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Alembic Pharmaceuticals Ltd., Seppic, PAI Pharma, SCL Lifesciences Ltd., AMGIS Lifescience Ltd., Organotechnie, HimPharm

38. Global Plant-Based Active Pharmaceutical Ingredients (API) Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Plant-Based Active Pharmaceutical Ingredients (API) Market

40. Plant-Based Active Pharmaceutical Ingredients (API) Market High Potential Countries, Segments and Strategies

• 40.1 Plant-Based Active Pharmaceutical Ingredients (API) Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Plant-Based Active Pharmaceutical Ingredients (API) Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Plant-Based Active Pharmaceutical Ingredients (API) Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer